Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy

RECOMMENDED

Thrombosis and Stroke

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

N Engl J Med.

Carrier M, Abou-Nassar K, Mallick R, Tagalakis V, Shivakumar S, Schattner A, Kuruvilla P, Hill D, Spadafora S, Marquis K, Trinkaus M, Tomiak A, Lee AYY, Gross PL, Lazo-Langner A, El-Maraghi R, Goss G, Le Gal G, Stewart D, Ramsay T, Rodger M, Witham D, Wells PS; AVERT Investigators

doi: 10.1056/NEJMoa1814468.

Thrombosis and Stroke

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

J Clin Oncol.

Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI, Wong SL, Balaban EP, Flowers CR, Francis CW, Gates LE, Kakkar AK, Levine MN, Liebman HA, Tempero MA, Lyman GH, Falanga A

doi: 10.1200/JCO.19.01461.

Thrombosis and Stroke

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

Lancet Oncol.

Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A, Brenner B, Kakkar A, Rafii H, Solymoss S, Brilhante D, Monreal M, Bounameaux H, Pabinger I, Douketis J, International Initiative on Thrombosis and Cancer (ITAC) advisory panel.

doi: 10.1016/S1470-2045(19)30336-5.

Thrombosis and Stroke

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

doi: 10.1056/NEJMoa1711948.

Thrombosis and Stroke

Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Trial

JAMA.

Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Anderson JL, Li J, Rodriguez T Jr, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, Whipple B, Porche-Sorbet R, Napoli L, Merritt K, Thompson AM, Hyun G, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Dávila-Román V, Eby CS

doi: 10.1001/jama.2019.12085.

Thrombosis and Stroke

Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis

Lancet Haematol.

Dawwas GK, Brown J, Dietrich E, Park H

doi: 10.1016/S2352-

Thrombosis and Stroke

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

N Engl J Med.

Agnelli G, Becattini C, Meyer G, Muñoz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M, Caravaggio Investigators.

doi: 10.1056/NEJMoa1915103.

Thrombosis and Stroke

Venous thromboembolism prophylaxis strategies for people undergoing elective total knee replacement: a systematic review and network meta-analysis

Lancet Haematol.

Lewis S, Glen J, Dawoud D, Dias S, Cobb J, Griffin XL, Rossiter N, Reed M, Sharpin C, Stansby G, Barry P

doi: 10.1016/S2352-3026(19)30155-3.

Thrombosis and Stroke

Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study

Eur Heart J.

Ogdie A, Kay McGill N, Shin DB, Takeshita J, Jon Love T, Noe MH, Chiesa Fuxench ZC, Choi HK, Mehta NN, Gelfand JM

doi: 10.1093/eurheartj/ehx145.

Related content

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Trial

Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

Venous thromboembolism prophylaxis strategies for people undergoing elective total knee replacement: a systematic review and network meta-analysis

Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study